FMS - Fresenius Medical Care AG & Co. KGaA

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 520.19B
Enterprise Value 320.24B
Trailing P/E 9.03
Forward P/E 113.12
PEG Ratio (5 yr expected) 12.78
Price/Sales (ttm)N/A
Price/Book (mrq)1.57
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.79
52-Week Change 3-33.68%
S&P500 52-Week Change 31.73%
52 Week High 353.40
52 Week Low 330.99
50-Day Moving Average 336.21
200-Day Moving Average 338.52

Share Statistics

Avg Vol (3 month) 3235.97k
Avg Vol (10 day) 3249.38k
Shares Outstanding 5610.56M
Float 418.43M
% Held by Insiders 10.00%
% Held by Institutions 11.90%
Shares Short (Jul 31, 2019) 4486.14k
Short Ratio (Jul 31, 2019) 41.35
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 40.05%
Shares Short (prior month Jun 28, 2019) 4444.52k

Dividends & Splits

Forward Annual Dividend Rate 40.66
Forward Annual Dividend Yield 41.96%
Trailing Annual Dividend Rate 31.24
Trailing Annual Dividend Yield 33.70%
5 Year Average Dividend Yield 41.22
Payout Ratio 429.21%
Dividend Date 3May 31, 2019
Ex-Dividend Date 4May 17, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 4, 2012

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 7.33%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)4.64%
Return on Equity (ttm)11.97%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)5.15B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)3.69
Quarterly Earnings Growth (yoy)-74.50%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)105.19
Current Ratio (mrq)0.99
Book Value Per Share (mrq)21.29

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A